Linical Co., Ltd.

Tokyo Stock Exchange 2183.T

Linical Co., Ltd. Market Capitalization on January 29, 2025: USD 48.57 M

Linical Co., Ltd. Market Capitalization is USD 48.57 M on January 29, 2025, a -39.67% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Linical Co., Ltd. 52-week high Market Capitalization is USD 79.25 M on January 30, 2024, which is 63.16% above the current Market Capitalization.
  • Linical Co., Ltd. 52-week low Market Capitalization is USD 47.14 M on December 24, 2024, which is -2.95% below the current Market Capitalization.
  • Linical Co., Ltd. average Market Capitalization for the last 52 weeks is USD 58.29 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 2183.T

Linical Co., Ltd.

CEO Mr. Kazuhiro Hatano
IPO Date Oct. 27, 2008
Location Japan
Headquarters Shin-Osaka Brick Building
Employees 662
Sector Health Care
Industries
Description

Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariat; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.

Similar companies

2335.T

Cube System Inc.

USD 6.79

-0.32%

3179.T

Syuppin Co., Ltd.

USD 7.15

0.43%

3034.T

Qol Holdings Co., Ltd.

USD 9.48

0.36%

StockViz Staff

January 30, 2025

Any question? Send us an email